Liverpool Skyline

Public Health Institute

Prof Vivian Hope

Prof Vivian Hope

Telephone: 0151 231 4332

ORCID

Biography

Viv joined the Public Health Institute in November 2016 as Professor of Public Health. Prior to that Viv was a Principal Scientist at Public Health England and also a Senior Lecturer at London School of Hygiene and Tropical Medicine. He has also held positions at Imperial College London and the University of Birmingham.

The focus of Viv’s work has been on the health harms, particularly infections, associated with drug use and sexual health. His other interests include homelessness and LGBT health.

Degrees

University of Bath, Bath, United Kingdom, PhD
University of Birmingham, Birmingham, United Kingdom, MMedSci
Royal Holloway University of London, Egham, United Kingdom, BSc (Hons)

Publications

Highlighted publications

Hibbert MP, Porcellato LA, Brett CE, Hope VD. 2019. Associations with drug use and sexualised drug use among women who have sex with women (WSW) in the UK: Findings from the LGBT Sex and Lifestyles Survey International Journal of Drug Policy, DOI Author Url Publisher Url Public Url

Harris M, Brathwaite R, McGowan CR, Ciccarone D, Gilchrist G, McCusker M, O'Brien K, Dunn J, Scott J, Hope V. 2018. 'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London. Harm Reduction Journal, 15 :23-23 DOI Author Url Publisher Url Public Url

Lewer D, Harris M, Hope V. 2017. Opiate injection–associated skin, soft tissue, and vascular infections, England, UK, 1997–2016 Emerging Infectious Diseases, 23 :1400-1403 DOI Author Url Public Url

Hope VD, Cullen KJ, Smith J, Jessop L, Parry J, Ncube F. 2016. Is the recent emergence of mephedrone injecting in the United Kingdom associated with elevated risk behaviours and blood borne virus infection? Euro Surveill, 21 DOI Author Url Public Url

Hope VD, Harris R, McVeigh J, Cullen KJ, Smith J, Parry JV, DeAngelis D, Ncube F. 2016. Risk of HIV and hepatitis B and C over time among men who inject image and performance enhancing drugs in England and Wales: Results from cross-sectional prevalence surveys, 1992-2013 Journal of Acquired Immune Deficiency Syndromes, 71 :331-337 DOI Author Url Public Url

Hope VD, Harris RJ, De Angelis D, Croxford S, Marongiu A, Parry JV, Ncube F. 2014. Two decades of successes and failures in controlling the transmission of HIV through injecting drug use in England and Wales, 1990 to 2011 Eurosurveillance, 19 DOI Author Url

Dubois-Arber F, Jeannin A, Spencer B, Gervasoni J-P, Graz B, Elford J, Hope V, Lert F, Ward H, Haour-Knipe M, Low N, van de Laar M. 2010. Mapping HIV/STI behavioural surveillance in Europe. BMC Infect Dis, 10 :290 DOI Author Url Public Url

Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. 2008. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis, 8 :120 DOI Author Url Public Url

Rhodes T, Stoneman A, Hope V, Hunt N, Martin A, Judd A. 2006. Groin injecting in the context of crack cocaine and homelessness: From 'risk boundary' to 'acceptable risk'? International Journal of Drug Policy, 17 :164-170 DOI Author Url

Hickman M, Higgins V, Hope V, Bellis M, Tilling K, Walker A, Henry J. 2004. Injecting drug use in Brighton, Liverpool, and London: Best estimates of prevalence and coverage of public health indicators Journal of Epidemiology and Community Health, 58 :766-771 DOI Author Url

Hope VD, Rogers PA, Jordan L, Paine TC, Barnett S, Parry JV, Gill ON. 2002. Sustained increase in the sharing of needles and syringes among drug users in England and Wales. AIDS, 16 :2494-2496 DOI Author Url

Marongiu A, Hope VD, Parry JV, Ncube F. Male IDUs who have sex with men in England, Wales and Northern Ireland: are they at greater risk of bloodborne virus infection and harm than those who only have sex with women? Sex Transm Infect, 88 :456-461 DOI Author Url

Hope VD, Palmateer N, Wiessing L, Marongiu A, White J, Ncube F, Goldberg D. A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation. Am J Public Health, 102 :122-125 DOI Author Url

Hope VD, MacArthur C, Mullis D, Radcliffe K. Relation between information and advice provision to male GUM clinic attendees and sexual orientation and ethnic group. Sex Transm Infect, 76 :198-202 DOI Author Url

Hope VD, MacArthur C. Safer sex and social class: findings from a study of men using the 'gay scene' in the West Midlands region of the United Kingdom. AIDS Care, 10 :81-88 DOI Author Url

Journal article

Lewer D, Freer J, King E, Larney S, Degenhardt L, Tweed EJ, Hope VD, Harris M, Millar T, Hayward A, Ciccarone D, Morley KI. 2019. Frequency of healthcare utilisation by adults who use illicit drugs: a systematic review and meta-analysis. Addiction, DOI Author Url Public Url

Hibbert MP, Wolton A, Weeks H, Ross M, Brett CE, Porcellato LA, Hope VD. 2019. Psychosocial and sexual factors associated with recent sexual health clinic attendance and HIV testing among trans people in the UK. BMJ Sex Reprod Health, DOI Author Url Public Url

Hickman M, Dillon JF, Elliott L, De Angelis D, Vickerman P, Foster G, Donnan P, Eriksen A, Flowers P, Goldberg D, Hollingworth W, Ijaz S, Liddell D, Mandal S, Martin N, Beer LJZ, Drysdale K, Fraser H, Glass R, Graham L, Gunson RN, Hamilton E, Harris H, Harris M, Harris R, Heinsbroek E, Hope V, Horwood J, Inglis SK, Innes H, Lane A, Meadows J, McAuley A, Metcalfe C, Migchelsen S, Murray A, Myring G, Palmateer NE, Presanis A, Radley A, Ramsay M, Samartsidis P, Simmons R, Sinka K, Vojt G, Ward Z, Whiteley D, Yeung A, Hutchinson SJ. 2019. Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol). BMJ Open, 9 :e029538 DOI Author Url Publisher Url Public Url

Chem ED, Van Hout MC, Hope V. 2019. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: A systematic review and meta-analysis BMC Infectious Diseases, 19 DOI Author Url Public Url

Hibbert MP, Porcellato LA, Brett CE, Hope VD. 2019. Associations with drug use and sexualised drug use among women who have sex with women (WSW) in the UK: Findings from the LGBT Sex and Lifestyles Survey International Journal of Drug Policy, DOI Author Url Publisher Url Public Url

Njoroge J, Hope V, O’Halloran C, Edmundson C, Glass R, Parry JV, Ncube F. 2019. Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the United Kingdom? Epidemiology and Infection, 147 :1-8 DOI Author Url Publisher Url Public Url

Packer S, Pichon B, Thompson S, Neale J, Njoroge J, Kwiatkowska R, Oliver I, Doumith M, Telfer M, Buunaaisie C, Ellen H, Hopewell-Kelly N, Desai M, Hope VD, Williams M, Kearns A, Hickman M, Gobin M. 2019. Clonal expansion of community-associated meticillin-resistant Staphylococcus aureus (MRSA) in people who inject drugs (PWID): prevalence, risk factors and molecular epidemiology, Bristol, United Kingdom, 2012 to 2017 Eurosurveillance, 24 DOI Author Url Publisher Url Public Url

Dunleavy K, Hope V, Roy K, Taylor A. 2019. People who inject drugs experiences of skin and soft tissue infections and harm reduction: A qualitative study. International Journal of Drug Policy, 65 :65-72 DOI Author Url Public Url

Glass R, Hope VD, Njoroge J, Edmundson C, Smith J, McVeigh J, Parry J, Desai M. 2019. Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15 Drug and Alcohol Dependence, 195 :40-44 DOI Author Url Publisher Url Public Url

Trickey A, May MT, Hope V, Ward Z, Desai M, Heinsbroek E, Hickman M, Vickerman P. 2018. Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK Drug and Alcohol Dependence, 192 :118-124 DOI Author Url Public Url

Ward Z, Platt L, Sweeney S, Hope VD, Maher L, Hutchinson S, Palmateer N, Smith J, Craine N, Taylor A, Martin N, Ayres R, Dillon J, Hickman M, Vickerman P. 2018. Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets? Addiction, DOI Author Url Public Url

Harris M, Brathwaite R, McGowan CR, Ciccarone D, Gilchrist G, McCusker M, O'Brien K, Dunn J, Scott J, Hope V. 2018. 'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London. Harm Reduction Journal, 15 :23-23 DOI Author Url Publisher Url Public Url

Dunleavy K, Munro A, Roy K, Hutchinson S, Palmateer N, Knox T, Goldberg D, Hope V, Campbell J, Hamilton E, Liddell D, Penrice G, Taylor A. 2018. Spore forming bacteria infections and people who inject drugs: Implications for harm reduction. Int J Drug Policy, 53 :45-54 DOI Author Url Public Url

Hope VD, McVeigh J, Smith J, Glass R, Njoroge J, Tanner C, Parry JV, Ncube F, Desai M. 2017. Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15 Drug and Alcohol Dependence, 179 :83-86 DOI Author Url Publisher Url Public Url

Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M. 2017. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs Cochrane Database of Systematic Reviews, 2017 DOI Author Url Public Url

O'Halloran C, Cullen K, Njoroge J, Jessop L, Smith J, Hope V, Ncube F. 2017. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland International Journal of Drug Policy, 46 :34-40 DOI Author Url Public Url

Hope VD, Iversen J, Cullen KJ, Parry JV, Maher L, Nucbe F. 2017. Injection into the jugular vein among people who inject drugs in the United Kingdom: Prevalence, associated factors and harms Int J Drug Policy, 46 :28-33 DOI Author Url Public Url

Lewer D, Harris M, Hope V. 2017. Opiate injection–associated skin, soft tissue, and vascular infections, England, UK, 1997–2016 Emerging Infectious Diseases, 23 :1400-1403 DOI Author Url Public Url

Bates G, Hope V, McVeigh J. 2017. HIV among people using anabolic steroids in the United Kingdom: an overview HIV Nursing, 17 :20-23 Public Url

Bundle N, Bubba L, Coelho J, Kwiatkowska R, Cloke R, King S, Rajan-Iyer J, Courtney-Pillinger M, Beck CR, Hope V, Lamagni T, Brown CS, Jermacane D, Glass R, Desai M, Gobin M, Balasegaram S, Anderson C. 2017. Ongoing outbreak of invasive and non-invasive disease due to group A Streptococcus (GAS) type emm66 among homeless and people who inject drugs in England and Wales, January to December 2016. Euro Surveill, 22 DOI Author Url Public Url

Hope VD, Cullen KJ, Smith J, Jessop L, Parry J, Ncube F. 2016. Is the recent emergence of mephedrone injecting in the United Kingdom associated with elevated risk behaviours and blood borne virus infection? Euro Surveill, 21 DOI Author Url Public Url

Iversen J, Hope VD, McVeigh J. 2016. Access to needle and syringe programs by people who inject image and performance enhancing drugs International Journal of Drug Policy, 31 :199-200 DOI Author Url Public Url

Platt L, Reed J, Minozzi S, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Hickman M. 2016. Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs Cochrane Database of Systematic Reviews, 2016 DOI Author Url Public Url

Hope VD, Harris R, McVeigh J, Cullen KJ, Smith J, Parry JV, DeAngelis D, Ncube F. 2016. Risk of HIV and hepatitis B and C over time among men who inject image and performance enhancing drugs in England and Wales: Results from cross-sectional prevalence surveys, 1992-2013 Journal of Acquired Immune Deficiency Syndromes, 71 :331-337 DOI Author Url Public Url

Hope VD, Scott J, Cullen KJ, Parry JV, Ncube F, Hickman M. 2015. Going into the groin: Injection into the femoral vein among people who inject drugs in three urban areas of England. Drug Alcohol Depend, 152 :239-245 DOI Author Url Public Url

Hope VD, Mcveigh J, Marongiu A, Evans-Brown M, Smith J, Kimergård A, Parry JV, Ncube F. 2015. Injection site infections and injuries in men who inject image- and performance-enhancing drugs: Prevalence, risks factors, and healthcare seeking Epidemiology and Infection, 143 :132-140 DOI Author Url

Hope VD, Harris RJ, De Angelis D, Croxford S, Marongiu A, Parry JV, Ncube F. 2014. Two decades of successes and failures in controlling the transmission of HIV through injecting drug use in England and Wales, 1990 to 2011 Eurosurveillance, 19 DOI Author Url

Hedrich D, Kalamara E, Sfetcu O, Pharris A, Noor A, Wiessing L, Hope V, de laar MV. 2013. Human immunodeficiency virus among people who inject drugs: Is risk increasing in Europe? Eurosurveillance, 18 :7-12 DOI Author Url

Hope VD, McVeigh J, Marongiu A, Evans-Brown M, Smith J, Kimergård A, Croxford S, Beynon CM, Parry JV, Al Bellis M, Ncube F. 2013. Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: A cross-sectional study BMJ Open, 3 DOI Author Url Public Url

Vickerman P, Martin NK, Roy A, Beattie T, Jarlais DD, Strathdee S, Wiessing L, Hickman M, EMCDDA Collaborative Group . 2013. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug Alcohol Depend, 132 :172-181 DOI Author Url

Mills HL, Colijn C, Vickerman P, Leslie D, Hope V, Hickman M. 2012. Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK. Drug Alcohol Depend, 126 :324-332 DOI Author Url

Hope V, Jeannin A, Spencer B, Gervasoni JP, van de Laar MJ, Dubois-Arber F, Dubois-Arber F, Spencer B, Hope V, Elford J, Lert F, Ward H, Low N, Haour-Knipe M, Jeannin A, Gervasoni JP, Pellaz MJ, Graz B, van de Laar M. 2011. Mapping HIV-related behavioural surveillance among injecting drug users in Europe, 2008 Eurosurveillance, 16 DOI Author Url Publisher Url

Presanis AM, Gill ON, Chadborn TR, Hill C, Hope V, Logan L, Rice BD, Delpech VC, Ades AE, De Angelis D. 2010. Insights into the rise in HIV infections, 2001 to 2008: a Bayesian synthesis of prevalence evidence. AIDS, 24 :2849-2858 DOI Author Url

Dubois-Arber F, Jeannin A, Spencer B, Gervasoni J-P, Graz B, Elford J, Hope V, Lert F, Ward H, Haour-Knipe M, Low N, van de Laar M. 2010. Mapping HIV/STI behavioural surveillance in Europe. BMC Infect Dis, 10 :290 DOI Author Url Public Url

Elford J, Jeannin A, Spencer B, Gervasoni JP, van de Laar MJ, Dubois-Arber F, HIV and STI Behavioural Surveillance Mapping Group . 2009. HIV and STI behavioural surveillance among men who have sex with men in Europe. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 14 DOI Author Url

Sweeting MJ, Hope VD, Hickman M, Parry JV, Ncube F, Ramsay ME, De Angelis D. 2009. Hepatitis C infection among injecting drug users in England and Wales (1992-2006): there and back again? Am J Epidemiol, 170 :352-360 DOI Author Url

Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. 2008. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis, 8 :120 DOI Author Url Public Url

Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M. 2006. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infect Dis, 6 :93 DOI Author Url Public Url

Huntington S, Hope V, Hutchinson S, Goldberg D, Ncube F. 2006. Diversity of needle exchange provision in the UK: findings from a national survey. Euro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin, 11 DOI Author Url

Rhodes T, Stoneman A, Hope V, Hunt N, Martin A, Judd A. 2006. Groin injecting in the context of crack cocaine and homelessness: From 'risk boundary' to 'acceptable risk'? International Journal of Drug Policy, 17 :164-170 DOI Author Url

Hope VD, Judd A, Hickman M, Sutton A, Stimson GV, Parry JV, Gill ON. 2005. HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years. AIDS, 19 :1207-1214 DOI Author Url

Sutton AJ, Gay NJ, Edmunds WJ, Andrews NJ, Hope VD, Gill ON. 2005. Modelling the characteristics of the male injecting drug user population in England and Wales International Journal of Drug Policy, 16 :176-182 DOI Author Url

Akbulut D, Dennis J, Gent M, Grant KA, Hope V, Ohai C, McLauchlin J, Mithani V, Mpamugo O, Ncube F, de Souza-Thomas L. 2005. Wound botulism in injectors of drugs: upsurge in cases in England during 2004. Euro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin, 10 :172-174 Author Url

Hope VD, Gilbert G, Munro H, Ncube F, Gill ON. 2004. Improving targeted hepatitis B vaccination BMJ, 329: :1059-1059 DOI Author Url

Hickman M, Higgins V, Hope V, Bellis M, Tilling K, Walker A, Henry J. 2004. Injecting drug use in Brighton, Liverpool, and London: Best estimates of prevalence and coverage of public health indicators Journal of Epidemiology and Community Health, 58 :766-771 DOI Author Url

Hahne S, Crowcroft N, White J, Ncube F, Hope VD, de Souza L, Brett M, Roy K, Goldberg D. 2004. Ongoing outbreak of tetanus in injecting drug users in the UK Eurosurveillance, 8 Author Url

Craine N, Walker AM, Williamson S, Brown A, Hope VD. 2004. Hepatitis B and hepatitis C seroprevalence and risk behaviour among community-recruited drug injectors in North West Wales. Communicable disease and public health / PHLS, 7 :216-219 Author Url

Hope VD, Rogers PA, Jordan L, Paine TC, Barnett S, Parry JV, Gill ON. 2002. Sustained increase in the sharing of needles and syringes among drug users in England and Wales. AIDS, 16 :2494-2496 DOI Author Url

Lamagni TL, Hope VD, Davison KL, Parry JV, Gill ON. 2001. Failure to vaccinate current injecting drug users against hepatitis B in England and Wales. Communicable disease and public health / PHLS, 4 :71-72 Author Url

Lamagni TL, Davison KL, Hope VD, Luutu JW, Newham JA, Parry JV, Gill ON. 1999. Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996. Communicable disease and public health / PHLS, 2 :174-177 Author Url

Hope VD, MacArthur C. 1997. Acceptability of clinics for sexually transmitted diseases among users of the "gay scene" in the West Midlands Sexually Transmitted Infections, 73 :299-302 DOI Author Url

Madden PB, Lamagni T, Hope V, Bennett D, Goldberg D. 1997. The HIV epidemic in injecting drug users. Communicable disease report. CDR review, 7 Author Url

Hope VD, Parry JV, Ncube F, Hickman M. Not in the vein: 'missed hits', subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom. Int J Drug Policy, 28 :83-90 DOI Author Url Public Url

Croxford S, Platt L, Hope VD, Cullen KJ, Parry JV, Ncube F. Sex work amongst people who inject drugs in England, Wales and Northern Ireland: findings from a National Survey of Health Harms and Behaviours. Int J Drug Policy, 26 :429-433 DOI Author Url

Martin NK, Foster GR, Vilar J, Ryder S, Cramp ME, Gordon F, Dillon JF, Craine N, Busse H, Clements A, Hutchinson SJ, Ustianowski A, Ramsay M, Goldberg DJ, Irving W, Hope V, De Angelis D, Lyons M, Vickerman P, Hickman M. HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact. J Viral Hepat, 22 :399-408 DOI Author Url Public Url

Cullen KJ, Hope VD, Croxford S, Shute J, Ncube F, Parry JV. Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey. Epidemiol Infect, 143 :1398-1407 DOI Author Url

Hope VD, Ncube F, Parry JV, Hickman M. Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England. Epidemiol Infect, 143 :120-131 DOI Author Url

Wiessing L, Ferri M, Grady B, Kantzanou M, Sperle I, Cullen KJ, EMCDDA DRID group , Hatzakis A, Prins M, Vickerman P, Lazarus JV, Hope VD, Matheï C. Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention. PLoS One, 9 :e103345 DOI Author Url Public Url

Hope VD, Cullen KJ, Croxford S, Parry JV, Ncube F. Factors associated with the use of cleaned needles and syringes among people who inject drugs in the UK: who should we target to minimise the risks? Int J Drug Policy, 25 :924-927 DOI Author Url

Hope VD, Hickman M, Parry JV, Ncube F. Factors associated with recent symptoms of an injection site infection or injury among people who inject drugs in three English cities. Int J Drug Policy, 25 :303-307 DOI Author Url

MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, Taylor A, Roy K, Aspinall E, Goldberg D, Rhodes T, Hedrich D, Salminen M, Hickman M, Hutchinson SJ. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy, 25 :34-52 DOI Author Url

Platt L, Jolley E, Rhodes T, Hope V, Latypov A, Reynolds L, Wilson D. Factors mediating HIV risk among female sex workers in Europe: a systematic review and ecological analysis. BMJ Open, 3 DOI Author Url Public Url

Jolley E, Rhodes T, Platt L, Hope V, Latypov A, Donoghoe M, Wilson D. HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy. BMJ Open, 2 DOI Author Url Public Url

Marongiu A, Hope VD, Parry JV, Ncube F. Male IDUs who have sex with men in England, Wales and Northern Ireland: are they at greater risk of bloodborne virus infection and harm than those who only have sex with women? Sex Transm Infect, 88 :456-461 DOI Author Url

Hickman M, Hope V, Platt L, Higgins V, Bellis M, Rhodes T, Taylor C, Tilling K. Estimating prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia. Drug Alcohol Rev, 25 :131-140 DOI Author Url

Hope VD, Eramova I, Capurro D, Donoghoe MC. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect, 142 :270-286 DOI Author Url Public Url

Palmateer NE, Hope VD, Roy K, Marongiu A, White JM, Grant KA, Ramsay CN, Goldberg DJ, Ncube F. Infections with spore-forming bacteria in persons who inject drugs, 2000-2009. Emerg Infect Dis, 19 :29-34 DOI Author Url Public Url

Hope V, Parry JV, Marongui A, Ncube F. Hepatitis C infection among recent initiates to injecting in England 2000-2008: Is a national hepatitis C action plan making a difference? J Viral Hepat, 19 :55-64 DOI Author Url

Hope VD, Palmateer N, Wiessing L, Marongiu A, White J, Ncube F, Goldberg D. A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation. Am J Public Health, 102 :122-125 DOI Author Url

Harris RJ, Hope VD, Morongiu A, Hickman M, Ncube F, DE Angelis D. Spatial mapping of hepatitis C prevalence in recent injecting drug users in contact with services. Epidemiol Infect, 140 :1054-1063 DOI Author Url

Harris RJ, Ramsay M, Hope VD, Brant L, Hickman M, Foster GR, De Angelis D. Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis. Eur J Public Health, 22 :187-192 DOI Author Url

Sutton AJ, House T, Hope VD, Ncube F, Wiessing L, Kretzschmar M. Modelling HIV in the injecting drug user population and the male homosexual population in a developed country context. Epidemics, 4 :48-56 DOI Author Url

Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, Ncube F, Parry JV. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat, 18 :262-270 DOI Author Url

Hope VD, Marongiu A, Parry JV, Ncube F. The extent of injection site infection in injecting drug users: findings from a national surveillance study. Epidemiol Infect, 138 :1510-1518 DOI Author Url

De Angelis D, Sweeting M, Ades A, Hickman M, Hope V, Ramsay M. An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales. Stat Methods Med Res, 18 :361-379 DOI Author Url

Lamagni TL, Neal S, Keshishian C, Hope V, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A. Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003-2004. Clin Microbiol Infect, 14 :1002-1009 DOI Author Url

Hope VD, Ncube F, Hickman M, Judd A, Parry JV. Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements? J Viral Hepat, 14 :653-660 DOI Author Url

Hickman M, Hope V, Brady T, Madden P, Jones S, Honor S, Holloway G, Ncube F, Parry J. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004. J Viral Hepat, 14 :645-652 DOI Author Url

Judd A, Hickman M, Hope VD, Sutton AJ, Stimson GV, Ramsay ME, Gill ON, Parry JV. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales? J Viral Hepat, 14 :584-591 DOI Author Url

Sutton AJ, Gay NJ, Edmunds WJ, Andrews NJ, Hope VD, Gilbert RL, Piper M, Gill ON. Modelling the hepatitis B vaccination programme in prisons. Epidemiol Infect, 134 :231-242 DOI Author Url

Brown AE, Tomkins SE, Logan LE, Lamontagne DS, Munro HL, Hope VD, Righarts A, Blackham JE, Rice BD, Chadborn TR, Tookey PA, Parry JV, Delpech V, Gill ON, Fenton KA. Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: where are we now? Sex Transm Infect, 82 :4-10 DOI Author Url

Turner KME, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, May M, Taylor A, De Angelis D, Cameron S, Parry J, Lyons M, Goldberg D, Allen E, Hickman M. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction, 106 :1978-1988 DOI Author Url

Hickman M, Hope V, Coleman B, Parry J, Telfer M, Twigger J, Irish C, Macleod J, Annett H. Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action. J Public Health (Oxf), 31 :374-382 DOI Author Url

Sutton AJ, Hope VD, Mathei C, Mravcik V, Sebakova H, Vallejo F, Suligoi B, Brugal MT, Ncube F, Wiessing L, Kretzschmar M. A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study. J Viral Hepat, 15 :809-816 DOI Author Url

Hickman M, McDonald T, Judd A, Nichols T, Hope V, Skidmore S, Parry JV. Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial. J Viral Hepat, 15 :250-254 DOI Author Url

Hope VD, Hickman M, Tilling K. Capturing crack cocaine use: estimating the prevalence of crack cocaine use in London using capture-recapture with covariates. Addiction, 100 :1701-1708 DOI Author Url

Platt L, Hickman M, Rhodes T, Mikhailova L, Karavashkin V, Vlasov A, Tilling K, Hope V, Khutorksoy M, Renton A. The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage. Addiction, 99 :1430-1438 DOI Author Url

Fitch C, Rhodes T, Hope VD, Stimson GV, Renton A. The role of rapid assessment methods in drug use epidemiology Bulletin on narcotics, :61-72

Jones JA, Salmon JE, Djuretic T, Nichols G, George RC, Gill ON, Brazier JS, Brett MM, Duerden BI, Fry NK, Hall V, Hope V, Lieftucht A, McLauchlin J, Pitcher DG, Weild A. An outbreak of serious illness and death among injecting drug users in England during 2000. J Med Microbiol, 51 :978-984 DOI Author Url

Hope VD, Judd A, Hickman M, Lamagni T, Hunter G, Stimson GV, Jones S, Donovan L, Parry JV, Gill ON. Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working? Am J Public Health, 91 :38-42 DOI Author Url

Hope VD, MacArthur C, Mullis D, Radcliffe K. Relation between information and advice provision to male GUM clinic attendees and sexual orientation and ethnic group. Sex Transm Infect, 76 :198-202 DOI Author Url

Crampin AC, Lamagni TL, Hope VD, Newham JA, Lewis KM, Parry JV, Gill ON. The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales. Epidemiol Infect, 121 :381-386 DOI Author Url

Hope VD, MacArthur C. Safer sex and social class: findings from a study of men using the 'gay scene' in the West Midlands region of the United Kingdom. AIDS Care, 10 :81-88 DOI Author Url

Hope VD, MacArthur C. Accessibility of genitourinary medicine clinics. Genitourin Med, 72 :52-55 DOI Author Url

Hope VD, MacArthur C. A comparison of HIV related advice in genitourinary medicine clinics with different histories. Genitourin Med, 72 :286-289 DOI Author Url

Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Addiction, 113 :545-563 DOI Author Url Public Url

Zahnow R, McVeigh J, Bates G, Hope V, Kean J, Campbell J, Smith J. Identifying a typology of men who use anabolic androgenic steroids (AAS). Int J Drug Policy, 55 :105-112 DOI Author Url Publisher Url Public Url

Heinsbroek E, Glass R, Edmundson C, Hope V, Desai M. Patterns of injecting and non-injecting drug use by sexual behaviour in people who inject drugs attending services in England, Wales and Northern Ireland, 2013-2016. Int J Drug Policy, 55 :215-221 DOI Author Url Public Url

Edmundson C, Heinsbroek E, Glass R, Hope V, Mohammed H, White M, Desai M. Sexualised drug use in the United Kingdom (UK): A review of the literature. Int J Drug Policy, 55 :131-148 DOI Author Url Publisher Url Public Url

Harris M, Brathwaite R, Scott J, Gilchrist G, Ciccarone D, Hope V, McGowan CR. Drawing attention to a neglected injecting-related harm: a systematic review of AA amyloidosis among people who inject drugs. Addiction, 113 :1790-1801 DOI Author Url Publisher Url Public Url

Rafia R, Dodd PJ, Brennan A, Meier PS, Hope VD, Ncube F, Byford S, Tie H, Metrebian N, Hellier J, Weaver T, Strang J. An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence Addiction, 111 :1616-1627 DOI Author Url Public Url

Hope VD, Ncube F, Dennis J, McLauchlin J. Wound botulism: increase in cases in injecting drug users, United Kingdom, 2004 Eurosurveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin, 8 Author Url

Sweeney S, Ward Z, Platt L, Guinness L, Hickman M, Hope V, Maher L, Iversen J, Hutchinson SJ, Smith J, Ayres R, Hainey I, Vickerman P. Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs. Addiction, 114 :560-570 DOI Author Url Public Url

Hibbert MP, Brett CE, Porcellato LA, Hope VD. Psychosocial and sexual characteristics associated with sexualised drug use and chemsex among men who have sex with men (MSM) in the UK. Sex Transm Infect, 95 :342-350 DOI Author Url Publisher Url Public Url

Hope VD, Harris RJ, Vickerman P, Platt L, Shute J, Cullen KJ, Ijaz S, Mandal S, Ncube F, Desai M, Parry JV. A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs. Euro Surveill, 23 DOI Author Url Publisher Url Public Url

Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen Y-F, Azim T, Mehta SH, Milloy M-J, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis, 18 :1397-1409 DOI Author Url Publisher Url Public Url

Chapters

Hope V, Iversen J. 2019. Infections and risk among people who use image and performance enhancing drugs. Van De Ven K, Mulrooney KJD, McVeigh J. Human Enhancement Drugs :85-100 Routledge. Oxford. 978-1-138-55279-1 Publisher Url

Report

Hay G, Rael Dos Santos A, Reed H, Hope V. 2019. Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2016/17: Sweep 13 report Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2016/17: Sweep 13 report Author Url Publisher Url

Begley E, McVeigh J, Hope VD, Bates G, Glass R, Campbell J, Tanner C, Kean J, Morgan G, Acreman D, Smith J. 2017. Image and Performance Enhancing Drugs 2016 National Survey Results Image and Performance Enhancing Drugs 2016 National Survey Results

Hope VD, Giraudon I, Kalamara E, Hedrich D. 2017. Drug-related infectious diseases in Europe, Update from the EMCDDA expert network: October 2017. DOI Publisher Url

Platt L, Sweeney S, Ward Z, Guinness L, Hickman M, Hope V, Hutchinson S, Maher L, Iversen J, Craine N, Taylor A, Munro A, Parry J, Smith J, Vickerman P. Assessing the impact and cost-effectiveness of needle and syringe provision and opioid substitution therapy on hepatitis C transmission among people who inject drugs in the UK: an analysis of pooled data sets and economic modelling DOI Publisher Url

Editorial/letter to the editor

McGowan CR, Harris M, Platt L, Hope V, Rhodes T. 2018. Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it? International Journal of Drug Policy, 58 :31-36 DOI Author Url Publisher Url Public Url

McVeigh J, Kimergård A, Bates G, Hope VD, Ncube F. 2016. Harm reduction interventions should encompass people who inject image and performance enhancing drugs BMJ (Online), 353 DOI Author Url

Hope VD, Mandal S, Cullen KJ, Balogun K, Ncube F. 2015. Hepatitis B vaccination for people who inject drugs. Lancet, 385 :115-116 DOI Author Url

Glass R, Hope VD, Tanner C, Desai M. 'Slamming' among men who have sex with men accessing general drug services, in response to Schmidt, AJ et al., 2016, Illicit drug use among gay and bisexual men in 44 cities: Findings from the European MSM Internet Survey (EMIS). Int J Drug Policy, 49 :24-25 DOI Author Url

Desai M, Bourne A, Hope V, Halkitis PN. Sexualised drug use: LGTB communities and beyond. Int J Drug Policy, 55 :128-130 DOI Author Url Publisher Url

Conference publication

Ward Z, Sweeney S, Platt L, Guinness L, Maher L, Hope V, Hickman M, Smith J, Ayres R, Hainey I, Chamberlain T, Vickerman P. 2018. The cost-effectiveness of needle and syringe provision in preventing transmission of Hepatitis C virus in people who inject drugs JOURNAL OF HEPATOLOGY, International Liver Congress (ILC) 68 :S146-S147 DOI Author Url

Hope V, Cullen KJ, Parry JV, Ncube F. 2015. The impact of 25 years of sero‐behavioural surveillance of blood borne viral infections among people who inject drugs in the United Kingdom Journal of Viral Hepatitis., 15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD) 22 :5-5 Publisher Url

Cullen KJ, Hope VD, Croxford S, Shute J, Ncube F, Parry JV. 2014. P1284 11 Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in the United Kingdom: new findings using an avidity testing algorithm. Journal of Hepatology, 49th Annual Meeting of the European Association for the Study of the Liver (EASL 2014) 60 :S518-S518 DOI Publisher Url

Hope V, McVeigh J, Marongiu A, Evans-Brown M, Smith J, Kimergard A, Croxford S, Beynon C, Parry J, Bellis PM, Ncube F. 2013. Prevalence of, and risk factors for, human immunodeficiency virus, hepatitis B and hepatitis C infections among men who inject image- and performance-enhancing drugs in England & Wales HIV MEDICINE, 14 :2-2 Author Url

Hope V. 2001. Epidemiology of hepatitis C virus in injecting drug users in england and wales: implications for HCV drug therapy Journal of Hepatology, The 36th Annual Meeting of EASL 34 :127-127 Publisher Url

Hope V, Cullen KJ, Parry JV, Ncube F. P127: Factors associated with undiagnosed hepatitis C infection among people who inject drugs and missed opportunities for testing in the United Kingdom Journal of Viral Hepatitis, 15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD) 22 :84-85 DOI

Thesis/Dissertation

Hope V. 2010. Studies on in vitro photosynthetic response and the culture environment in Pisum.

Other

O'Halloran C, Cullen K, Njoroge J, Jessop L, Smith J, Hope V, Ncube F. Corrigendum to "The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland" [Int. J. Drug Policy 46 (2017) 34-40]. Int J Drug Policy, 57 :133-135 DOI Author Url

Engagement & Impact

Conference organisation:

26th Harm Reduction International Conference (HR19), Porto, Portugal, 2019, Member of the Programme Committee, https://www.hri.global/conference-2019. 2018

25th International Harm Reduction Conference, Montréal, Canada, 2017, Programme Committee Member, https://www.hri.global/conference-2017. 2016

24th International Harm Reduction Conference, Kuala Lumpur, Malaysia, 2015, Programme Committee Member, https://www.hri.global/conference-2015. 2014

Editorial boards:

International Journal of Drug Policy, Guest Editor for the themed collection on ' Sexualised drug use: LGBT communities and beyond'., http://www.ijdp.org/pb/assets/raw/Health%20Advance/journals/drupol/Call_for_papers_announcement.pdf. 2017

Hepatology, Medicine and Policy, Associate Editor, https://hmap.biomedcentral.com/about. 2015

External committees:

Advisory group for the NIHR Career Development Grant: "Promoting skin & soft tissue infection care and preventing AA amyloidosis among people who inject drugs in the UK: A mixed methods study.", LSHTM, Member. 2016

International Advisory group for the SPHERE-C Project, ECDC / RKI, Member, https://www.rki.de/DE/Content/InfAZ/H/HepatitisC/SPHERE-C.html. 2016

Image & Performance Enhancing Drugs Working Group (IPEDs), Advisory Council on the Misuse of Drugs. 2016

Drug-related infectious diseases (DRID) expert network, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), National Expert for the UK, http://www.emcdda.europa.eu/activities/drid. 2004

Research Grants Awarded:

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2017 Rapid Communication on ‘Drug-related infectious diseases’, Grant value (£): €8,000.

Harm Reduction International, The global state of harm reduction funding, Grant value (£): 22,500.

Public Health Wales, Image and performance enhancing drug use in Wales, Grant value (£): 25,000.

Other Professional Activity:

I regularly review papers for a number of journals, including the International Journal of Drug Policy, EuroSurveillance, Addiction, and Drug & Alcohol Dependence..